Shenmai Baofei prescription

Shenmai Baofei prescription is a Traditional Chinese Medicine (TCM) herbal formula developed by The First Affiliated Hospital of Henan University of Chinese Medicine. It is specifically designed for the treatment of elderly patients recovering from COVID-19 infection, particularly those identified through syndrome differentiation as having patterns such as Qi and Yin deficiency. The prescription is part of a syndrome-differentiation-based therapeutic strategy aimed at reducing re-hospitalization rates and mortality while improving functional recovery, mental health, and overall safety in patients recently discharged after medium, severe, or critical COVID-19 infection. In clinical trial settings, it is often evaluated alongside or as an alternative to the Shenqi Baofei prescription, depending on the patient's specific TCM syndrome.

Other names

Shenmai Baofei formulaShenmai Baofei decoction